4-Hydroxyacetophenone
CAS 99-93-4
4-Hydroxyacetophenone (CAS 99-93-4) is a pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 41428.57142857143 nM | 14 | - |
| - | GI50 | 25800 nM | 4 | - |
| - | MIC | 121 ug.mL-1 | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Hydroxyacetophenone | 1541733 | SU | MTHSPL |
| HYDROXYACETOPHENONE | 1541733 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 4-Hydroxyacetophenone used for in pharmaceutical contexts?
4-Hydroxyacetophenone (CAS 99-93-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 4-Hydroxyacetophenone?
No adverse-event association or SIDER side-effect rows are rendered for 4-Hydroxyacetophenone in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 4-Hydroxyacetophenone also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Hydroxyacetophenone with EU status "permitted".
What clinical phase is 4-Hydroxyacetophenone in?
No phase 1-4 clinical development badge is rendered for 4-Hydroxyacetophenone because the matched compound identifier rows do not contain a max-phase value.